Trial Profile
A phase III trial of exenatide once-weekly suspension in patients with type-2 diabetes mellitus.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 16 Jan 2012
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 16 Jan 2012 New trial record